Spire Healthcare (SPI.L)
Spire Healthcare is a major UK private hospital operator providing surgical and diagnostic services across a national network of facilities.
What Spire Healthcare does
Spire Healthcare is a leading private healthcare provider in the UK. The company operates a network of private hospitals, clinics, and specialist cancer centers, offering a range of surgical and diagnostic services to patients funded by private medical insurance, self-pay, and the National Health Service (NHS).
Themes: private healthcare services, UK elective surgery, diagnostic imaging services
Fundamentals
- Price£2.33 as of 2026-08-03 close
- Market capn/a company fundamentals are not available for UK-listed companies in our data
- 1-year return+10.4% 2025-08-01 close £2.11 → 2026-08-03 close £2.33
- P/En/a company fundamentals are not available for UK-listed companies in our data
- Net marginn/a company fundamentals are not available for UK-listed companies in our data
- Gross marginn/a company fundamentals are not available for UK-listed companies in our data
- ROEn/a company fundamentals are not available for UK-listed companies in our data
- Debt / equityn/a company fundamentals are not available for UK-listed companies in our data
- Revenue growth (YoY)n/a company fundamentals are not available for UK-listed companies in our data
- Revenue CAGR (3y)n/a company fundamentals are not available for UK-listed companies in our data
- Betan/a we do not track a market benchmark for UK-listed companies
Dividend: company fundamentals are not available for UK-listed companies in our data.
How Spire Healthcare looks technically
Spire Healthcare (SPI.L) is trading 12.9% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 8 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 11, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 68, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 6 trading days ago (its momentum flipped positive). It made a new 20-day high about 3 trading days ago. Trading volume is unusually light — only about 0% of its 30-day average.
Trend
| Distance from the 200-day | +12.9% | it is trading 12.9% above its 200-day average, the long-term trend line — a longer-term uptrend |
|---|---|---|
| 50-day moving average | £2.18 | its average price over the last 50 trading days — a short-term trend line — is £2.18 |
| 200-day moving average | £2.06 | its average price over the last 200 trading days — the long-term trend line — is £2.06 |
| Since the 50/200 cross | 8 sessions | its 50-day average crossed above its 200-day average about 8 trading days ago — a "golden cross", a bullish long-term signal |
| Trend strength (14-day ADX) | 10.8 | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 11, below the 25 that marks a real trend) |
Momentum
| 14-day RSI | 68.0 | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 68, neither overbought (above 70) nor oversold (below 30) |
|---|---|---|
| Since the MACD crossed zero | 6 sessions | MACD, a trend-momentum gauge, turned bullish about 6 trading days ago (its momentum flipped positive) |
Range
| 52-week high | £2.56 | its highest closing price over the past year (about 252 trading days) was £2.56 |
|---|---|---|
| From the 52-week high | -9.2% | it is 9.2% below its 52-week high (its highest price of the past year) |
| Above the 52-week low | +63.9% | it is 63.9% above its 52-week low (its lowest price of the past year) |
| Below the 52-week high | 9.2% | it is 9.2% below its highest point of the past year |
| Since a 20-day breakout | 3 sessions | it made a new 20-day high about 3 trading days ago |
| Since a 55-day breakout | 3 sessions | it made a new 55-day high about 3 trading days ago |
| All-time high | £4.11 | its highest closing price on record is £4.11 (set on 2016-09-16) |
| From the all-time high | -43.3% | it is 43.3% below its all-time high |
| All-time low | £0.0211 | its lowest closing price on record is £0.0211 (set on 2022-06-14) |
| Above the all-time low | +10,943% | it is 10942.7% above its all-time low |
Volatility
| Band width vs its own 6 months | 43rd percentile | day-to-day price swings are about average versus its own recent 6-month history |
|---|---|---|
| Bollinger bands (20-day, ±2σ) | £2.09 – £2.23 – £2.38 | most of its recent trading has stayed between about £2.09 and £2.38 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles |
Volume
| Volume vs its 30-day average | 0.00× | trading volume is unusually light — only about 0% of its 30-day average |
|---|
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Broke out to a new 20-day high · trendless / choppy (low ADX) | Learn: moving average · golden cross · adx · rsi · macd · breakout · volume and relative volume
Based on daily closing prices as of 2026-08-03. Describes past price behavior only — informational, not financial advice.
Key risks (from latest filing)
["Dependence on NHS contracts and funding policy changes","Competition for clinical and nursing staff recruitment and retention","Regulatory requirements and quality standards of the Care Quality Commission (CQC)"]
Competitors & peers
- Nuffield Health
- Circle Health Group (PureHealth)
- Ramsay Health Care (RHC.AX)
- HCA Healthcare (HCA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare SPI.L vs…
Frequently asked questions
What does Spire Healthcare (SPI.L) do?
Spire Healthcare is a leading private healthcare provider in the UK. The company operates a network of private hospitals, clinics, and specialist cancer centers, offering a range of surgical and diagnostic services to patients funded by private medical insurance, self-pay, and the National Health Service (NHS).
Who are Spire Healthcare's (SPI.L) competitors?
Notable peers of Spire Healthcare (SPI.L) include Nuffield Health, Circle Health Group (PureHealth), Ramsay Health Care and HCA Healthcare. This peer set is informational only — not financial advice.
Is Spire Healthcare (SPI.L) overbought or oversold right now?
Spire Healthcare (SPI.L) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 68, in the neutral middle (as of 2026-08-03). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on SPI.L come from?
Fundamentals and prices come from market data. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from market data, shown with their as-of date.